Symbols / CLPT Stock $11.08 -1.16% ClearPoint Neuro, Inc.

Healthcare • Medical Devices • United States • NCM
CLPT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Joseph Michael Burnett
Exch · Country NCM · United States
Market Cap 332.25M
Enterprise Value 340.98M
Income -25.54M
Sales 36.97M
FCF (ttm) -9.63M
Book/sh 0.95
Cash/sh 1.55
Employees 172
Insider 10d —
IPO May 22, 2012
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -13.60
PEG 0.61
P/S 8.99
P/B 11.61
P/C —
EV/EBITDA -15.87
EV/Sales 9.22
Quick Ratio 4.94
Current Ratio 5.91
Debt/Eq 207.82
LT Debt/Eq —
EPS (ttm) -0.90
EPS next Y -0.81
EPS Growth —
Revenue Growth 34.00%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-03-17
ROA -20.41%
ROE -95.64%
ROIC —
Gross Margin 61.38%
Oper. Margin -50.38%
Profit Margin -69.08%
Shs Outstand 29.99M
Shs Float 25.33M
Insider Own 8.25%
Instit Own 52.22%
Short Float 16.07%
Short Ratio 7.08
Short Interest 4.65M
52W High 30.10
vs 52W High -63.19%
52W Low 8.27
vs 52W Low 33.98%
Beta 1.18
Impl. Vol. 6.25%
Rel Volume 0.36
Avg Volume 750.38K
Volume 267.59K
Target (mean) $25.00
Tgt Median $25.00
Tgt Low $20.00
Tgt High $30.00
# Analysts 2
Recom None
Prev Close $11.21
Price $11.08
Change -1.16%
About

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$25.00
Mean price target
2. Current target
$11.08
Latest analyst target
3. DCF / Fair value
$-5.78
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$11.08
Low
$20.00
High
$30.00
Mean
$25.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-18 main B. Riley Securities Buy → Buy $20
2026-03-05 main B. Riley Securities Buy → Buy $18
2025-04-25 main B. Riley Securities Buy → Buy $28
2025-04-01 main Stifel Buy → Buy $25
2025-01-28 main B. Riley Securities Buy → Buy $20
2025-01-21 main Lake Street Buy → Buy $30
2024-08-27 main Lake Street Buy → Buy $15
2024-03-13 reit Stifel Buy → Buy $9
2023-10-24 init Stifel — → Buy $8
2023-08-09 main Lake Street Buy → Buy $15
2021-03-18 init Lake Street — → Buy $32
2020-07-17 init B. Riley Securities — → Buy $8
News
RSS: Latest CLPT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 FLETCHER R JOHN Director — 1,270 $9.10 $11,557
2026-04-01 GIRIN PASCAL E R Director — 755 $9.10 $6,870
2026-04-01 RICHARDS TIMOTHY T Director — 442 $9.10 $4,022
2026-03-19 BURNETT JOSEPH MICHAEL Chief Executive Officer — 20,942 $3.24 $67,852
2026-03-12 BURNETT JOSEPH MICHAEL Chief Executive Officer — 84,829 — —
2026-03-12 D'ALESSANDRO DANILO Chief Financial Officer — 32,627 — —
2026-03-12 STIGALL L JEREMY Officer — 30,995 — —
2026-03-12 SABRA MAZIN Chief Operating Officer — 26,101 — —
2026-03-11 D'ALESSANDRO DANILO Chief Financial Officer — 4,145 — —
2026-03-11 STIGALL L JEREMY Officer — 8,291 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
36.97
+17.78%
31.39
+31.04%
23.95
+16.56%
20.55
Operating Revenue
36.97
+17.78%
31.39
+31.04%
23.95
+16.56%
20.55
Cost Of Revenue
14.28
+16.39%
12.27
+18.63%
10.34
+47.31%
7.02
Reconciled Cost Of Revenue
14.28
+16.39%
12.27
+18.63%
10.34
+47.31%
7.02
Gross Profit
22.69
+18.67%
19.12
+40.46%
13.61
+0.61%
13.53
Operating Expense
46.86
+20.59%
38.86
+7.75%
36.06
+20.75%
29.86
Research And Development
13.90
+12.14%
12.39
+5.83%
11.71
+7.48%
10.89
Selling General And Administration
32.96
+24.54%
26.46
+8.68%
24.35
+28.37%
18.97
Selling And Marketing Expense
16.46
+13.70%
14.48
+14.95%
12.60
+34.59%
9.36
General And Administrative Expense
16.50
+37.64%
11.99
+1.96%
11.76
+22.32%
9.61
Other Gand A
16.50
+37.64%
11.99
+1.96%
11.76
+22.32%
9.61
Total Expenses
61.13
+19.58%
51.12
+10.18%
46.40
+25.81%
36.88
Operating Income
-24.16
-22.45%
-19.73
+12.08%
-22.45
-37.44%
-16.33
Total Operating Income As Reported
-24.16
-22.45%
-19.73
+12.08%
-22.45
-37.44%
-16.33
EBITDA
-20.86
-26.57%
-16.48
+21.48%
-20.99
-34.74%
-15.58
Normalized EBITDA
-20.86
-26.57%
-16.48
+21.48%
-20.99
-34.74%
-15.58
Reconciled Depreciation
2.24
+17.55%
1.90
+30.61%
1.46
+87.52%
0.78
EBIT
-23.10
-25.64%
-18.38
+18.10%
-22.45
-37.25%
-16.35
Net Income
-25.54
-35.03%
-18.91
+14.37%
-22.09
-34.40%
-16.43
Pretax Income
-25.48
-34.83%
-18.90
+14.43%
-22.09
-34.40%
-16.43
Net Non Operating Interest Income Expense
-1.18
-234.75%
0.87
+125.91%
0.39
+576.54%
-0.08
Interest Expense Non Operating
2.39
+361.00%
0.52
—
0.08
Net Interest Income
-1.18
-234.75%
0.87
+125.91%
0.39
+576.54%
-0.08
Interest Expense
2.39
+361.00%
0.52
—
0.08
Interest Income Non Operating
1.21
-12.73%
1.39
+260.10%
0.39
—
Interest Income
1.21
-12.73%
1.39
+260.10%
0.39
—
Other Income Expense
-0.15
-265.00%
-0.04
-37.93%
-0.03
-31.82%
-0.02
Other Non Operating Income Expenses
-0.15
-265.00%
-0.04
-37.93%
-0.03
-31.82%
-0.02
Tax Provision
0.06
+358.33%
0.01
—
—
Tax Rate For Calcs
0.00
+0.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-25.54
-35.03%
-18.91
+14.37%
-22.09
-34.40%
-16.43
Net Income From Continuing Operation Net Minority Interest
-25.54
-35.03%
-18.91
+14.37%
-22.09
-34.40%
-16.43
Net Income From Continuing And Discontinued Operation
-25.54
-35.03%
-18.91
+14.37%
-22.09
-34.40%
-16.43
Net Income Continuous Operations
-25.54
-35.03%
-18.91
+14.37%
-22.09
-34.40%
-16.43
Normalized Income
-25.54
-35.03%
-18.91
+14.37%
-22.09
-34.40%
-16.43
Net Income Common Stockholders
-25.54
-35.03%
-18.91
+14.37%
-22.09
-34.40%
-16.43
Diluted EPS
—
-0.70
+22.22%
-0.90
-32.35%
-0.68
Basic EPS
—
-0.70
+22.22%
-0.90
-32.35%
-0.68
Basic Average Shares
—
27.03
+9.85%
24.61
+1.75%
24.18
Diluted Average Shares
—
27.03
+9.85%
24.61
+1.75%
24.18
Diluted NI Availto Com Stockholders
-25.54
-35.03%
-18.91
+14.37%
-22.09
-34.40%
-16.43
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
97.75
+149.42%
39.19
-8.14%
42.66
-23.12%
55.49
Current Assets
63.60
+90.63%
33.36
-7.77%
36.17
-29.32%
51.18
Cash Cash Equivalents And Short Term Investments
45.92
+128.43%
20.10
-13.12%
23.14
-38.28%
37.49
Cash And Cash Equivalents
45.92
+128.43%
20.10
-13.12%
23.14
-16.20%
27.61
Other Short Term Investments
—
—
0.00
-100.00%
9.87
Receivables
6.55
+38.96%
4.71
+46.78%
3.21
+20.49%
2.67
Accounts Receivable
6.55
+38.96%
4.71
+46.78%
3.21
+20.49%
2.67
Gross Accounts Receivable
7.75
+33.30%
5.81
+26.07%
4.61
+66.76%
2.77
Allowance For Doubtful Accounts Receivable
-1.20
-9.09%
-1.10
+21.43%
-1.40
-1300.00%
-0.10
Inventory
8.36
+21.80%
6.86
-13.25%
7.91
-14.96%
9.30
Raw Materials
7.05
+28.15%
5.50
-14.89%
6.47
-0.72%
6.51
Finished Goods
4.81
+32.99%
3.62
+193.27%
1.23
-52.17%
2.58
Prepaid Assets
—
—
—
—
Other Current Assets
2.77
+64.53%
1.68
-11.88%
1.91
+10.85%
1.72
Total Non Current Assets
34.15
+486.11%
5.83
-10.22%
6.49
+50.56%
4.31
Net PPE
11.05
+117.07%
5.09
+2.79%
4.95
+83.38%
2.70
Gross PPE
12.77
+98.45%
6.43
+9.09%
5.90
+31.95%
4.47
Accumulated Depreciation
-1.72
-27.85%
-1.34
-42.12%
-0.94
+46.58%
-1.77
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
—
—
0.00
-100.00%
0.26
Other Properties
12.28
+106.47%
5.95
+9.90%
5.41
+35.09%
4.01
Leases
0.48
+0.00%
0.48
+0.00%
0.48
+141.29%
0.20
Goodwill And Other Intangible Assets
21.39
0.00
-100.00%
1.04
+1.26%
1.03
Goodwill
7.47
0.00
—
—
Other Intangible Assets
13.92
+2776.45%
0.48
-53.51%
1.04
+1.26%
1.03
Other Non Current Assets
1.70
+131.56%
0.73
+48.48%
0.49
-14.80%
0.58
Total Liabilities Net Minority Interest
69.73
+405.27%
13.80
-35.78%
21.49
+15.51%
18.60
Current Liabilities
10.77
+3.98%
10.35
+39.34%
7.43
+9.46%
6.79
Payables And Accrued Expenses
4.04
+44.87%
2.79
+92.95%
1.45
-38.13%
2.34
Payables
1.26
-6.27%
1.34
+240.97%
0.39
+44.49%
0.27
Accounts Payable
1.26
-6.27%
1.34
+240.97%
0.39
+44.49%
0.27
Current Accrued Expenses
2.79
+92.14%
1.45
+37.70%
1.05
-49.01%
2.06
Pensionand Other Post Retirement Benefit Plans Current
4.36
-10.75%
4.88
+65.76%
2.95
+4.36%
2.82
Current Debt And Capital Lease Obligation
0.69
+24.60%
0.56
+31.37%
0.42
-24.42%
0.56
Current Capital Lease Obligation
0.69
+24.60%
0.56
+31.37%
0.42
-24.42%
0.56
Current Deferred Liabilities
1.67
-21.31%
2.12
-18.83%
2.61
+145.12%
1.07
Current Deferred Revenue
1.67
-21.31%
2.12
-18.83%
2.61
+145.12%
1.07
Total Non Current Liabilities Net Minority Interest
58.96
+1610.53%
3.45
-75.48%
14.06
+18.98%
11.81
Long Term Debt And Capital Lease Obligation
57.54
+1810.93%
3.01
-77.72%
13.52
+18.31%
11.43
Long Term Debt
49.08
—
9.95
+0.57%
9.89
Long Term Capital Lease Obligation
8.46
+181.00%
3.01
-15.61%
3.57
+132.90%
1.53
Non Current Deferred Liabilities
0.94
+114.45%
0.44
-19.41%
0.54
+38.72%
0.39
Non Current Deferred Revenue
0.58
+33.26%
0.44
-19.41%
0.54
+38.72%
0.39
Non Current Deferred Taxes Liabilities
0.35
0.00
—
—
Other Non Current Liabilities
0.49
—
—
—
Stockholders Equity
28.02
+10.36%
25.39
+19.91%
21.17
-42.60%
36.89
Common Stock Equity
28.02
+10.36%
25.39
+19.91%
21.17
-42.60%
36.89
Capital Stock
0.29
+6.52%
0.28
+11.74%
0.25
+0.41%
0.25
Common Stock
0.29
+6.52%
0.28
+11.74%
0.25
+0.41%
0.25
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
29.37
+6.34%
27.62
+12.03%
24.65
+0.30%
24.58
Ordinary Shares Number
29.37
+6.34%
27.62
+12.03%
24.65
+0.30%
24.58
Additional Paid In Capital
239.00
+10.40%
216.48
+11.95%
193.38
+3.41%
187.01
Retained Earnings
-216.91
-13.35%
-191.37
-10.97%
-172.46
-14.69%
-150.37
Total Equity Gross Minority Interest
28.02
+10.36%
25.39
+19.91%
21.17
-42.60%
36.89
Total Capitalization
77.10
+203.66%
25.39
-18.42%
31.12
-33.47%
46.78
Working Capital
52.84
+129.62%
23.01
-19.94%
28.74
-35.25%
44.39
Invested Capital
77.10
+203.66%
25.39
-18.42%
31.12
-33.47%
46.78
Total Debt
58.23
+1532.06%
3.57
-74.41%
13.94
+16.31%
11.99
Net Debt
3.15
—
—
—
Capital Lease Obligations
9.15
+156.59%
3.57
-10.62%
3.99
+90.73%
2.09
Net Tangible Assets
6.63
-73.90%
25.39
+26.11%
20.13
-43.86%
35.86
Tangible Book Value
6.63
-73.90%
25.39
+26.11%
20.13
-43.86%
35.86
Inventories Adjustments Allowances
-3.51
-55.20%
-2.26
—
—
Other Equity Interest
5.64
—
—
—
Other Inventories
—
0.27
+25.59%
0.21
+0.48%
0.21
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-23.93
-167.32%
-8.95
+34.77%
-13.72
+15.14%
-16.17
Cash Flow From Continuing Operating Activities
-23.93
-167.32%
-8.95
+34.77%
-13.72
+15.14%
-16.17
Net Income From Continuing Operations
-25.54
-35.03%
-18.91
+14.37%
-22.09
-34.40%
-16.43
Depreciation Amortization Depletion
2.24
+17.55%
1.90
+30.61%
1.46
+87.52%
0.78
Depreciation
2.07
+8.72%
1.90
+30.61%
1.46
+87.52%
0.78
Amortization Cash Flow
0.17
0.00
—
—
Depreciation And Amortization
2.24
+17.55%
1.90
+30.61%
1.46
+87.52%
0.78
Amortization Of Intangibles
0.17
0.00
—
—
Other Non Cash Items
0.99
+1843.14%
0.05
+173.91%
-0.07
+69.87%
-0.23
Stock Based Compensation
8.18
+18.43%
6.91
+13.62%
6.08
+47.33%
4.13
Provisionand Write Offof Assets
0.02
+107.09%
-0.30
-123.53%
1.26
+1175.21%
-0.12
Change In Working Capital
-9.81
-801.50%
1.40
+492.98%
-0.36
+91.70%
-4.29
Change In Receivables
-0.27
+77.78%
-1.21
+33.15%
-1.80
-754.98%
-0.21
Changes In Account Receivables
-0.27
+77.78%
-1.21
+33.15%
-1.80
-754.98%
-0.21
Change In Inventory
-0.10
-113.86%
0.74
-40.37%
1.25
+128.18%
-4.42
Change In Prepaid Assets
-0.40
-251.53%
0.26
+331.86%
-0.11
+90.71%
-1.22
Change In Payables And Accrued Expense
-7.52
-342.19%
3.10
+578.43%
-0.65
-140.79%
1.59
Change In Accrued Expense
—
—
—
—
Change In Other Working Capital
-0.32
+46.57%
-0.60
-135.18%
1.70
+229.51%
0.52
Change In Other Current Assets
-0.20
-400.00%
-0.04
-277.27%
0.02
+466.67%
-0.01
Change In Other Current Liabilities
-1.01
-16.46%
-0.87
-15.10%
-0.76
-39.56%
-0.54
Investing Cash Flow
0.61
+323.64%
-0.28
-103.07%
8.95
+183.36%
-10.74
Cash Flow From Continuing Investing Activities
0.61
+323.64%
-0.28
-103.07%
8.95
+183.36%
-10.74
Net PPE Purchase And Sale
-0.52
-89.82%
-0.28
+61.65%
-0.72
-183.40%
-0.25
Purchase Of PPE
-0.52
-89.82%
-0.28
+61.65%
-0.72
-183.40%
-0.25
Capital Expenditure
-0.52
-89.82%
-0.28
+73.83%
-1.05
+8.29%
-1.15
Net Investment Purchase And Sale
—
0.00
-100.00%
10.00
+204.28%
-9.59
Purchase Of Investment
—
—
0.00
+100.00%
-21.59
Sale Of Investment
—
0.00
-100.00%
10.00
-16.67%
12.00
Net Business Purchase And Sale
1.14
0.00
—
—
Net Intangibles Purchase And Sale
—
0.00
+100.00%
-0.33
+62.60%
-0.89
Purchase Of Intangibles
—
0.00
+100.00%
-0.33
+62.60%
-0.89
Financing Cash Flow
50.18
+710.78%
6.19
+1990.88%
0.30
-27.63%
0.41
Cash Flow From Continuing Financing Activities
50.18
+710.78%
6.19
+1990.88%
0.30
-27.63%
0.41
Net Issuance Payments Of Debt
48.09
+580.86%
-10.00
0.00
—
Issuance Of Debt
48.09
0.00
—
—
Repayment Of Debt
0.00
+100.00%
-10.00
0.00
—
Long Term Debt Issuance
48.09
0.00
—
—
Long Term Debt Payments
0.00
+100.00%
-10.00
0.00
—
Net Long Term Debt Issuance
48.09
+580.86%
-10.00
0.00
—
Net Common Stock Issuance
3.26
-79.79%
16.15
0.00
0.00
Proceeds From Stock Option Exercised
0.69
+47.84%
0.46
-8.30%
0.51
-32.08%
0.74
Net Other Financing Charges
-1.86
-337.74%
-0.42
-101.90%
-0.21
+37.50%
-0.34
Changes In Cash
26.87
+985.01%
-3.04
+32.16%
-4.47
+83.11%
-26.49
Beginning Cash Position
20.10
-13.12%
23.14
-16.20%
27.61
-48.96%
54.11
End Cash Position
46.97
+133.65%
20.10
-13.12%
23.14
-16.20%
27.61
Free Cash Flow
-24.45
-165.01%
-9.22
+37.55%
-14.77
+14.68%
-17.31
Interest Paid Supplemental Data
0.91
+89.17%
0.48
-35.40%
0.74
+42.07%
0.52
Income Tax Paid Supplemental Data
0.07
+11.29%
0.06
0.00
0.00
Change In Interest Payable
—
—
—
—
Common Stock Issuance
3.26
-79.79%
16.15
0.00
0.00
Issuance Of Capital Stock
3.26
-79.79%
16.15
0.00
0.00
Sale Of Business
1.14
0.00
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category